These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 31044478)
41. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients. Avancini J; Maragno L; Santi CG; Criado PR Clin Exp Dermatol; 2015 Dec; 40(8):851-9. PubMed ID: 26271788 [TBL] [Abstract][Full Text] [Related]
42. Drug reaction with eosinophilia and systemic symptoms: Pediatric case series and literature review. Oberlin KE; Rahnama-Moghadam S; Alomari AK; Haggstrom AN Pediatr Dermatol; 2019 Nov; 36(6):887-892. PubMed ID: 31423638 [TBL] [Abstract][Full Text] [Related]
43. Specific features of amoxicillin-associated Drug Reaction with Eosinophilia and Systemic Symptoms syndrome: a nationwide study. Largeau B; Agier MS; Beau-Salinas F; Pariente A; Maruani A; Vial T; Jonville-Béra AP J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):2415-2420. PubMed ID: 34459032 [TBL] [Abstract][Full Text] [Related]
44. Analysis of Individual Case Safety Reports of Severe Cutaneous Adverse Reactions in Korea. Kang MG; Sohn KH; Kang DY; Park HK; Yang MS; Lee JY; Kang HR Yonsei Med J; 2019 Feb; 60(2):208-215. PubMed ID: 30666843 [TBL] [Abstract][Full Text] [Related]
45. Drug reaction with eosinophilia and systemic symptoms in pediatric patients: A clinicopathological study of 16 cases in the National Center of Pharmacovigilance of Tunisia. Kaabi W; Zaiem A; Aouinti I; Charfi O; Kastalli S; El Aidli S; Daghfous R; Lakhoua G Therapie; 2019 Oct; 74(5):531-535. PubMed ID: 31023620 [TBL] [Abstract][Full Text] [Related]
46. Management and treatment outcome of DRESS patients in Europe: An international multicentre retrospective study of 141 cases. Kridin K; Brüggen MC; Walsh S; Bensaid B; Ranki A; Oppel E; Meyersburg D; Chua SL; Seeli C; Sandberg H; French LE; Vorobyev A; Ingen-Housz-Oro S J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):753-762. PubMed ID: 36479739 [TBL] [Abstract][Full Text] [Related]
47. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs. Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091 [TBL] [Abstract][Full Text] [Related]
48. Drug Reaction with Eosinophilia and Systemic Symptoms: Retrospective Analysis of 104 Cases over One Decade. Wang L; Mei XL Chin Med J (Engl); 2017 Apr; 130(8):943-949. PubMed ID: 28397724 [TBL] [Abstract][Full Text] [Related]
49. Co-Trimoxazole-Induced DRESS Syndrome: A Case Report. Paitorn L J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S227-30. PubMed ID: 27266243 [TBL] [Abstract][Full Text] [Related]
50. Late sequelae of drug reaction with eosinophilia and systemic symptoms (DRESS) cause thyroid dysfunction and thyroiditis: review of literature. Tempark T; Deekajorndech T; Chatproedprai S; Supornsilchai V; Wananukul S J Pediatr Endocrinol Metab; 2022 May; 35(5):567-575. PubMed ID: 35119800 [TBL] [Abstract][Full Text] [Related]
51. DRESS syndrome: clinical myths and pearls. Isaacs M; Cardones AR; Rahnama-Moghadam S Cutis; 2018 Nov; 102(5):322-326. PubMed ID: 30566546 [TBL] [Abstract][Full Text] [Related]
52. DRESS syndrome in a patient with cystic fibrosis: A case report. Gohy S; Froidure A; Lebecque P Pediatr Pulmonol; 2017 Apr; 52(4):E18-E21. PubMed ID: 27740720 [TBL] [Abstract][Full Text] [Related]
53. Management of Psychotropic Drug-Induced DRESS Syndrome: A Systematic Review. Bommersbach TJ; Lapid MI; Leung JG; Cunningham JL; Rummans TA; Kung S Mayo Clin Proc; 2016 Jun; 91(6):787-801. PubMed ID: 27126302 [TBL] [Abstract][Full Text] [Related]
54. [Drug reaction with eosinophilia and systemic symptoms]. Tehrany YA; Laffitte E; Grosgurin O; Spoerl D Rev Med Suisse; 2016 Apr; 12(513):684-6, 688-90. PubMed ID: 27197323 [TBL] [Abstract][Full Text] [Related]
55. A 10-years retrospective study on Severe Cutaneous Adverse Reactions (SCARs) in a tertiary hospital in Penang, Malaysia. Loo CH; Tan WC; Khor YH; Chan LC Med J Malaysia; 2018 Apr; 73(2):73-77. PubMed ID: 29703869 [TBL] [Abstract][Full Text] [Related]
56. A Case of Vancomycin-Induced Drug Reaction with Eosinophilia, Systemic Symptoms and Multiorgan Involvement Proven Using Lymphocyte Transformation Test. Chung KB; Hwang JH; Kim D Ann Dermatol; 2023 Apr; 35(2):140-145. PubMed ID: 37041708 [TBL] [Abstract][Full Text] [Related]
57. Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome in Children: A Case Report. Mattoussi N; Ben Mansour A; Essadam L; Guedri R; Fitouri Z; Ben Becher S J Investig Allergol Clin Immunol; 2017; 27(2):144-146. PubMed ID: 28398207 [No Abstract] [Full Text] [Related]
58. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first-line antituberculosis drugs: Two case reports and a review of the literature. Coster A; Aerts O; Herman A; Marot L; Horst N; Kenyon C; Vlieghe E; Hainaut P; Baeck M Contact Dermatitis; 2019 Nov; 81(5):325-331. PubMed ID: 31021423 [TBL] [Abstract][Full Text] [Related]
59. Drug reaction with eosinophilia and systemic symptoms (DRESS): A histopathology based analysis. Sasidharanpillai S; Govindan A; Riyaz N; Binitha MP; Muhammed K; Khader A; Reena Mariyath OK; Simin M; Subin K Indian J Dermatol Venereol Leprol; 2016; 82(1):28-36. PubMed ID: 26728807 [TBL] [Abstract][Full Text] [Related]
60. Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): A monocenter retrospective study of 20 cases. Brin C; Bernigaud C; Hua C; Duong TA; Gaudin O; Colin A; de Prost N; Wolkenstein P; Chosidow O; Ingen-Housz-Oro S Ann Dermatol Venereol; 2021 Sep; 148(3):168-171. PubMed ID: 33858692 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]